Economic impact of prescribing error prevention with computerized physician order entry of injectable antineoplastic drugs

Journal of Oncology Pharmacy Practice

Volumn 19, Issue 1, 2013, Pages 8-17

  Nerich, V ^a,b   Borg, C ^a,b   Villanueva, C ^a   Thiery Vuillemin, A ^a   Helias, P ^a   Rohrlich, P S ^a,b   Demarchi, M ^a   Pivot, X ^a,b   Limat, S ^a,b  

^a University Teaching Hospital of Besançon   (France)

^b INSERM   (France)

Author keywords

cancer; Clinical pharmacy; cost benefit analysis; prescribing error

Indexed keywords

ANTINEOPLASTIC AGENT;

ARTICLE; BODY SURFACE; BODY WEIGHT; CLINICAL PHARMACY; COMPUTERIZED PROVIDER ORDER ENTRY; COST BENEFIT ANALYSIS; CREATININE BLOOD LEVEL; HOSPITAL ADMISSION; HOSPITAL COST; HOSPITALIZATION; HUMAN; INAPPROPRIATE PRESCRIBING; MEDICATION ERROR; MONTE CARLO METHOD; PHARMACIST; PRIORITY JOURNAL; PUBLIC HEALTH INSURANCE; RESIDENT; TEACHING HOSPITAL;

ANTINEOPLASTIC AGENTS; COST-BENEFIT ANALYSIS; DECISION TREES; DRUG MONITORING; ELECTRONIC PRESCRIBING; FEMALE; FRANCE; HOSPITAL COSTS; HOSPITALS, UNIVERSITY; HUMANS; INAPPROPRIATE PRESCRIBING; INJECTIONS; MALE; MODELS, ECONOMIC; NEOPLASMS; ONCOLOGY SERVICE, HOSPITAL; PHARMACISTS; PHARMACY SERVICE, HOSPITAL; PHYSICIANS; PROFESSIONAL ROLE;

EID: 84874474665     PISSN: 10781552     EISSN: 1477092X     Source Type: Journal    
DOI: 10.1177/1078155212447974     Document Type: Article

References (30)

1. Bates DW. Using information technology to reduce rates of medication errors in hospitals. BMJ. 2000 ; 320 (7237). 788-791
2. Shane R. Computerized physician order entry: challenges and opportunities. Am J Health Syst Pharm. 2002 ; 59: 286-288
3. Kaushal R, Shojania K, Bates D. Effects of computerized physician order entry and clinical decision support systems on medication safety. A systematic review. Arch Intern Med. 2003 ; 163: 1409-1416
4. Oren E, Shaffer ER, Guglielmo BJ. Impact of emerging technologies on medication errors and adverse drug events. Am J Health Syst Pharm. 2003 ; 60: 1447-1458
5. Koppel R, Metlay JP, Cohen A, et al. Role of computerized physician order entry systems in facilitating medication errors. JAMA. 2005 ; 293: 1197-1203
6. Shulman R, Singer M, Goldstone J, et al. Medication errors: a prospective cohort study of hand-written and computerized physician order entry in the intensive care unit. Crit Care. 2005 ; 9: 516-521
7. Fernandez MJH, Baena-Canada JM, Bautista MJM, et al. Impact of computerised chemotherapy prescriptions on the prevention of medication errors. Clin Transl Oncol. 2006 ; 8 (11). 821-825
8. Serrano-Fabia A, Albert-Mari A, Almenar-Cubells D, et al. Multidisciplinary system for detecting medication errors in antineoplastic chemotherapy. J Oncol Pharm Pract. 2010 ; 16 (2). 105-112
9. Schwappach DL, Wernli M. Medication errors in chemotherapy: incidence, types and involvement of patients in prevention. A review of the literature. Eur J Canc Care. 2010 ; 19 (3). 285-292
10. Walsh KE, Dodd KS, Seetharaman K, et al. Medication errors among adults and children with cancer in the outpatient setting. J Clin Oncol. 2009 ; 27 (6). 891-896
11. Terceros Y, Chahine-Chakhtoura C, Malinowski J, et al. Impact of a pharmacy resident on hospital length of stay and drug-related cost. Ann Pharmacother. 2007 ; 41 (5). 742-748
12. O'Dell KM, Kucukarslan SN. Impact of the clinical pharmacist on readmission in patients with acute coronary syndrome. Ann Pharmacother. 2005 ; 39: 1423-1427
13. Ellis SL, Carter BL, Malone DC, et al. Clinical and economic impact of ambulatory care clinical pharmacists in management of dyslipidemia in older adults: the IMPROVE study. Impact of Managed Pharmaceutical Care on Resource Utilization and Outcomes in Veterans Affairs Medical Centers. Pharmacotherapy. 2000 ; 20: 1508-1516
14. Bouvy ML, Heerdink ER, Urquahart J, et al. Effect of a pharmacist-led intervention on diuretic compliance in heart failure patients: a randomised controlled study. J Card Fail. 2003 ; 9: 404-411
15. Leape LL, Cullen DJ, Clapp MD, et al. Pharmacist participation on physician rounds and adverse drug events in the intensive care unit. JAMA. 1999 ; 281 (3). 267-270
16. Kucukarslan SN, Peters M, Mlynarek M, et al. Pharmacists on rounding teams reduce preventable adverse drug events in hospital general medicine units. Arch Intern Med. 2003 ; 163: 2014-2018
17. Kaboli PJ, Hoth AB, McClimon BJ, et al. Clinical pharmacist and inpatient medical care: a systematic review. Arch Intern Med. 2006 ; 166: 955-964
18. Kopp BJ, Mrsan M, Erstad BL, et al. Cost implications of and potential adverse events prevented by interventions of a critical care pharmacist. Am J Health Syst Pharm. 2007 ; 64: 2483-2487
19. Bond CA, Raehl CL. Clinical and economic outcomes of a pharmacist-managed antimicrobial prophylaxis in surgical patients. Am J Health Syst Pharm. 2007 ; 64: 1935-1942
20. Haumschild MJ, Karfonta TL, Haumschild MS, et al. Clinical and economic outcomes of a fall-focused pharmaceutical intervention program. Am J Health Syst Pharm. 2003 ; 60: 1029-1032
21. Schumock GT, Butler MG, Meek PD, et al. Evidence of the economic benefit of clinical pharmacy services: 1996- 2000. Pharmacotherapy. 2003 ; 23 (1). 113-132
22. Finley PR, Rens HR, Pont JT, et al. Impact of a collaborative pharmacy practice model on the treatment of depression in primary care. Am J Health Syst Pharm. 2002 ; 59: 1518-1526
23. Cowper PA, Weinberger M, Hanlon JT, et al. The cost-effectiveness of a clinical pharmacist intervention among elderly outpatients. Pharmacotherapy. 1998 ; 18: 327-332
24. McMullin ST, Hennenfent JA, Ritchie DJ, et al. A prospective, randomized trial to assess the cost impact of pharmacist-initiated interventions. Arch Intern Med. 1999 ; 159: 2306-2309
25. Mutnick AH, Sterba KJ, Peroutka JA, et al. Cost savings and avoidance from clinical interventions. Am J Health Syst Pharm. 1997 ; 54: 393-396
26. Nerich V, Limat S, Demarchi M, et al. Computerized physician order entry of injectable antineoplastic drugs: an epidemiologic study of prescribing medication errors. Int J Med Inform. 2010 ; 79 (10). 699-706
27. Hatoum HT, Hutchinson RA, Elliott LR, et al. Physician's review of significant interventions by clinical pharmacist in inpatient care. Drug Intell Clin Pharm. 1988 ; 22: 980-982
28. Van Den Bemt PM, Postma MJ, Van Roon EN, et al. Cost-benefit analysis of the detection of prescribing errors by hospital pharmacy staff. Drug Saf. 2002 ; 25 (2). 135-143
29. de Rijdt T, Willems L, Simoens S. Economic effects of clinical pharmacy interventions: a literature review. Am J Health Syst Pharm. 2008 ; 65: 1161-1172
30. Olson LM, Desai S, Soto ML. Evaluation of pharmacist's intervention at a university teaching hospital. Can J Hosp Pharm. 2005 ; 58: 20-25